脓毒症休克患者血清代谢物全基因组关联研究
该研究为回顾性多中心队列研究,纳入澳大利亚、新西兰和英国27家医院收治的230例接受机械通气的成人脓毒症休克患者,均为Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock试验(NCT01448109)的亚组。对血清代谢物水平进行全基因组关联研究,发现两大酮体(3-羟基丁酸[rs2456680]和乙酰乙酸[rs2213037])及肌酐(rs6851961)达到全基因组显著性关联(p ≤ 5×10⁻⁸)。其中rs2213037位于醇脱氢酶基因簇,该基因簇编码与乙酰乙酸代谢相关的酶,为这一关联提供了合理性。三个SNP均与脓毒症风险、28天或90天死亡率或急性生理与慢性健康评分(脓毒症严重程度指标)无强关联。作者认为这些遗传关联可能反映饥饿反应而非脓毒症病理生理过程,但结果需在健康及疾病队列(包括不同 ancestry 人群)中进一步研究和重复。
要点
- 在230例脓毒症休克患者中,3-羟基丁酸(rs2456680)、乙酰乙酸(rs2213037)和肌酐(rs6851961)达到全基因组显著关联(p ≤ 5×10⁻⁸)。
- rs2213037位于醇脱氢酶基因簇,该基因簇编码与乙酰乙酸代谢相关的酶,为乙酰乙酸关联提供合理性。
- 三个SNP均与脓毒症风险、28天死亡率、90天死亡率或APACHE评分无强关联。
- 作者认为代谢物的遗传关联可能反映饥饿反应而非脓毒症病理生理,但结果需在健康及疾病队列(包括不同 ancestry 人群)中进一步研究和重复。
适用人群与场景
- 成人、危重、接受机械通气的脓毒症休克患者(n=230),为Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock试验(NCT01448109)的亚组。
- 来自澳大利亚、新西兰和英国27家参与医院站点收治的患者。
研究设计与关键结果
- 研究设计:回顾性多中心队列研究,纳入27家医院站点、3个国家的230例成人机械通气脓毒症休克患者,无干预。
- 全基因组关联研究显示:3-羟基丁酸(rs2456680)、乙酰乙酸(rs2213037)和肌酐(rs6851961)达到全基因组显著关联(p ≤ 5×10⁻⁸)。
- rs2213037位于醇脱氢酶基因簇,该基因簇编码与乙酰乙酸代谢相关的酶。
- 三个SNP均与脓毒症风险、28天死亡率、90天死亡率或急性生理与慢性健康评分(APACHE)无强关联。
证据类型、等级与局限
- 证据类型:回顾性多中心队列研究(全基因组关联研究)。
- 作者结论:代谢物的遗传关联可能反映饥饿反应而非脓毒症病理生理过程;结果需在健康及疾病队列(包括不同 ancestry 人群)中进一步研究和重复。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,脓毒症休克患者中代谢物(酮体、肌酐)的遗传关联可能反映饥饿反应而非脓毒症病理生理过程;该结果需进一步研究和重复,原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: We sought to assess whether genetic associations with metabolite concentrations in septic shock patients could be used to identify pathways of potential importance for understanding sepsis pathophysiology.
DESIGN: Retrospective multicenter cohort studies of septic shock patients.
SETTING: All participants who were admitted to 27 participating hospital sites in three countries (Australia, New Zealand, and the United Kingdom) were eligible for inclusion.
PATIENTS: Adult, critically ill, mechanically ventilated patients with septic shock (n = 230) who were a subset of the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock trial (ClinicalTrials.gov number: NCT01448109).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: A genome-wide association study was conducted for a range of serum metabolite levels for participants. Genome-wide significant associations (p ≤ 5 × 10-8) were found for the two major ketone bodies (3-hydroxybutyrate [rs2456680] and acetoacetate [rs2213037] and creatinine (rs6851961). One of these single-nucleotide polymorphisms (SNPs) (rs2213037) was located in the alcohol dehydrogenase cluster of genes, which code for enzymes related to the metabolism of acetoacetate and, therefore, presents a plausible association for this metabolite. None of the three SNPs showed strong associations with risk of sepsis, 28- or 90-day mortality, or Acute Physiology and Chronic Health Evaluation score (a measure of sepsis severity).
CONCLUSIONS: We suggest that the genetic associations with metabolites may reflect a starvation response rather than processes involved in sepsis pathophysiology. However, our results require further investigation and replication in both healthy and diseased cohorts including those of different ancestry.
参考来源
- Daubney ER, D'Urso S, Cuellar-Partida G, et al. A Genome-Wide Association Study of Serum Metabolite Profiles in Septic Shock Patients. Crit Care Explor. 2024. PMID: 38239409. doi:10.1097/CCE.0000000000001030
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。